Polaryx Therapeutics, Inc. (PLYX) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-07-21 | 8-K | Officer / Director Changes | SEC |
| 2026-07-17 | 8-K | Item 5.08, Other Events | SEC |
| 2026-05-28 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.